Kamada Ltd.
KMDA · NASDAQ
Market closed$7.05$0.140000 (+2.03%)After hours $7.05 · 0.00%
Key statistics
Previous close$6.91
Open$7.08
Day high$7.11
Day low$7.02
52-week high$9.35
52-week low$6.50
Market cap406.74M
Volume28.00K
Average volume44.79K
P/E ratio20.14
Forward P/E—
EPS0.35
Dividend yield+3.55%
Market context
Why it moved
KMDA shares edged higher amid modest buying interest, with no major company-specific news identified as the driver, suggesting the uptick reflects broader market sentiment and routine trading activity.
What is happening
Recent company-specific developments and publisher coverage.
Investing.com · July 13, 2026Kamada highlights study results on CYTOGAM in transplantsStock Titan · July 13, 2026Immune drug CYTOGAM tied to better outcomes in high‑risk lung transplant patientsAd Hoc News · July 7, 2026Kamada Ltd outlines plasma-derived therapies strategy. Investor focus on specialty biologics pipelinGlobeNewswire · May 13, 2026Kamada Reports First Quarter 2026 Financial Results andStock Titan · May 6, 2026Kamada will post quarterly results before markets open on May 13GlobeNewswire · May 6, 2026Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026Stock Titan · March 31, 2026Kamada shareholders face 25% tax holdback before April 7 dividend Benzinga · July 13, 2026Kamada Highlights Results Of An Investigator-initiated Study Of Cytogam, The Company’s Cytomegalovirus Immune Globulin, In The Management Of Cytomegalovirus In Solid Organ Transplantation Benzinga · June 1, 2026Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory Benzinga · May 13, 2026Kamada Q1 2026 Earnings Call: Complete Transcript Benzinga · May 13, 2026Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M vs $201.581M Est Benzinga · May 13, 2026Kamada Q1 EPS $0.07 Misses $0.12 Estimate, Sales $45.240M Miss $46.722M Estimate Benzinga · March 31, 2026Kamada Secures Israeli Tax Ruling On $0.25 Dividend, Allowing Reduced Withholding For Nasdaq Treaty Shareholders Mt Newswire · March 26, 2026Kamada Says San Antonio Plasma Collection Center Received US FDA Approval Benzinga · March 26, 2026Kamada Says FDA Approves Kamada Plasma's Collection Center In San Antonio